Clinical Trial Update: A Study of QY201 Tablet in Subjects With Moderate to Severe Atopic Dermatitis [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for QY201 Tablet in subjects with moderate to severe atopic dermatitis across Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• QY201 Tablet

Snippet

Sponsor: E-nitiate Biopharmaceuticals (Hangzhou) Co., Ltd. | Conditions: Atopic Dermatitis | Phase 1, Phase 2 | Status: UNKNOWN